Kamada (KMDA) Free Cash Flow Growth (1y) (2013 - 2026)
Kamada (KMDA) Free Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Kamada | 462.32 Mn | 432.85 Mn | 22.47 Mn | 165.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 165.71% |
| Mar 31, 2026 | -28.59% |
| Dec 31, 2025 | -40.27% |
| Sep 30, 2025 | -42.45% |
| Jun 30, 2025 | -40.88% |
| Mar 31, 2025 | -74.20% |
| Dec 31, 2024 | 54.52% |
| Sep 30, 2024 | 818.38% |
| Jun 30, 2024 | 495.96% |
| Mar 31, 2024 | 213,594.81% |
| Dec 31, 2023 | 455.43% |
| Sep 30, 2023 | 37,181.94% |
| Jun 30, 2023 | -71.84% |
| Mar 31, 2023 | -100.03% |
| Dec 31, 2022 | 33.11% |
| Sep 30, 2022 | 100.62% |
| Jun 30, 2022 | 619.10% |
| Mar 31, 2022 | 167.71% |
| Dec 31, 2021 | -95.03% |
| Sep 30, 2021 | -129.82% |